Advanced Wound Care Products Market Analysis - Global Industry, Size, Share, Trends and Forecast, 2014 – 2024

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Forthcoming | Report ID : ARC241

The global advanced wound care products market was valued at around $7 billion in 2016 and is expected to witness a growth over 8% during the forecast period of 2017 to 2024. Wound care products are generally classified into two main segments namely, traditional wound dressings (protecting wounds from external contaminants in a dry environment) and advanced wound care products (provides therapeutic effect for complicated wounds such as chronic and hard to heal wounds). Among these, traditional wound care products are widely preferred by healthcare professionals and consumers over advanced wound care products, primarily due to two main reasons - lower cost; and satisfactory healing of superficial wounds by dry dressings. Nevertheless, owing to the lower price of traditional wound dressings than advanced products, the advanced wound care products segment has surpassed the traditional products in terms of market value. Advanced wound care is generally used to treat complex wounds such as burns, surgical wounds, infected wounds, and chronic wounds. Typically, acute wound take nearly eight weeks to heal and follows normal stages of wound healing, whereas chronic wounds does not proceed through the normal healing stages. 
 
The global advanced wound care products market is segmented based on the type of application and geography. Based on applications, the market is segmented into moist wound care products (foam dressings, hydrogels, hydrocolloids, alginates, film dressings, antimicrobial dressings, others), biologics (skin substitutes, collagen, therapeutic growth factors) and negative pressure wound therapy (NPWT). Further, based on region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa (MEA). Amongst these regions, North America dominated the market in 2016 and is expected to maintain its dominance throughout the forecast period. This is attributed by the higher adoption of advanced wound care technologies in the region and large number of players operating in this market, which makes easy access of technologies for the patients and healthcare professionals. 
 
This research report is designed to analyze and estimate the performance, market demand, and size of the global advanced wound care products market across the world. This report includes historical data and forecasts and market size, value chain, product sales, their forecasts, and information on the products in pipeline and various other key factors that are boosting or impeding the growth of this market. Some of the major factors driving this market include rising awareness about the advanced wound care products, growing prevalence of chronic wounds due to the aging population, technological innovations, and growing incidence levels of diabetes and obesity. These factors are set to propel the growth of this market and provide immense growth opportunities for companies across the globe. There has been a significant rise in the number of patients suffering with obesity and diabetes in developing countries such as India and China over the recent years. Factors such as rapid urbanization, changing lifestyle habits, and supportive government reimbursement policies are bolstering this growth.
 
Presently, pricing pressure and government efforts to curb healthcare expenditure is hampering the growth of this market. Although pricing pressure is expected to pose a negative impact on this market, favorable demographics such as aging population and growing number of patients suffering from diabetes will drive the growth of this market.  
 
Some of the key players operating in this market include Smith & Nephew, Molnlycke Health Care, ConvaTec Group Plc, 3M Health Care, Coloplast, Medtronic (Covidien), Paul Hartmann, B.Braun Melsungen AG, Derma Sciences, Hollister Inc., Human Biosciences, Acelity L.P. Inc., and Medline Industries.
 


Related Reports

Meningococcal Vaccines Market (By Type: Combination Vaccines [MenHibrix, Menitorix], Conjugate Vaccines [Menactra, MenAfriVac, Meningitec, Menjugate, Menveo, NeisVac-C, Nimenrix, NmVac4-DT], Polysaccharide [Mencevax, Menomune, NmVac4, Others], Men B Vaccines [Bexsero, Trumenba], Others; By End User: Retail Pharmacies, Hospital Pharmacies, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction: Meningococcal vaccines are utilized to treat meningitis brought about by bacterium N. meningitidis. Beforehand there were no careful steps accessible to maintain a strategic distance from meningitis. Anti-infection agents alongside supplement supplements were utilized to treat this ailment after the disease was affirmed. In any case, with the approach of the meningoco

Real-time PCR (qPCR) and Digital PCR (dPCR) Market (By Technology: Digital, Quantitative; By Product: Instruments, Reagents and Consumables, Software & Services; By Application: Research [Forensic and Others], Clinical [Pathogen Testing, Oncology Testing, Blood Screening, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Real-time PCR (qPCR) & Digital PCR (dPCR) market is expected to grow at noteworthy CAGR around 8.1 % throughout the forecast period and reach around US$ 4.2 billion by 2026. In order to amplify or make more copies of the deoxyribonucleic acid (DNA) sequence

Nebulizer Market (By Type: Mesh, Pneumatic [Portable, Standalone], Ultrasonic [Portable, Standalone) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Nebulizer market is expected to grow at noteworthy CAGR around 6.2 % throughout the forecast period and reach around US$ 1.4 billion by 2026. Nebulizer is a medical device that converts the medicine into a nebula and directly into the pulmonary system. Nebuliza

Motion Preservation Devices Market (By Product: Total Disc Replacement Devices, Prosthetic Nucleus Replacement Devices, Posterior Dynamic Devices, Facet Replacement Devices; By Surgery: Open Spine Surgery, Minimally Invasive Spine Surgery; By End Use: Hospitals, Ambulatory Surgical Centers, Orthopedic Centers and Clinics) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Motion Preservation Devices market is expected to grow at noteworthy CAGR around 10.5 % throughout the forecast period and reach around US$ 1.5 billion by 2026. In spinal disorders, movement preservation devices are used. Motion conservation devices are used to

Hemoglobinopathy Market (By Type: Thalassemia [Beta Thalassemia, Alpha Thalassemia], Sickle Cell Disease, Other Hb Variants Diseases; By Therapy: Thalassemia [Beta Thalassemia, Alpha Thalassemia], Sickle Cell Disease, Other Hb Variants Diseases; By Diagnosis: Thalassemia [Beta Thalassemia, Alpha Thalassemia], Sickle Cell Disease, Other Hb variants diseases) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Hemoglobinopathy market is expected to grow at noteworthy CAGR around 10 % throughout the forecast period and reach around US$ 12 billion by 2026. Hemoglobinopathy is a genetic disorder that causes structural abnormalities in hemoglobin molecules. Hemoglobinopa

Cart Summary